Inventor
FRANK JOEL
US16 patents
⚠️ This page may combine multiple inventors who share the name “FRANK JOEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LIPOCINE INC
14 patentsUS9498485B2Nov 22, 2016
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
LIPOCINE INC23 citations92
US11370811B1Jun 28, 2022
(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparation and use
LIPOCINE INC8 citations85
US9757389B2Sep 12, 2017
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
LIPOCINE INC8 citations84
US12208103B1Jan 28, 2025
Compositions and methods for treating CNS disorders
LIPOCINE INC2 citations73
US11872235B1Jan 16, 2024
Bioavailable solid state (17-β)-Hydroxy-4-Androsten-3-one esters
LIPOCINE INC1 citations73
US11298365B2Apr 12, 2022
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
LIPOCINE INC2 citations73
US12186327B2Jan 7, 2025
Oral allopregnanolone compositions and methods of use
LIPOCINE INC2 citations72
US11969434B1Apr 30, 2024
Oral allopregnanolone compositions and methods of use
LIPOCINE INC4 citations72
US12409185B1Sep 9, 2025
Oral allopregnanolone compositions and methods of use
LIPOCINE INC1 citations62
US12351600B2Jul 8, 2025
(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparation and use
LIPOCINE INC0 citations62
US12171770B1Dec 24, 2024
Bioavailable solid state (17-beta)-hydroxy-4-androsten-3-one esters
LIPOCINE INC0 citations62
US12527805B1Jan 20, 2026
Compositions and methods for treating CNS disorders
LIPOCINE INC0 citations61
US11707467B2Jul 25, 2023
(17-ß)-3-oxoandrost-4-en-17YL tridecanoate compositions and methods of their preparation and use
LIPOCINE INC0 citations59
US12576090B1Mar 17, 2026
Oral brexanolone compositions and methods of preparation and use
LIPOCINE INC0 citations50